Federal officials approved a new non-opioid painkiller developed by a Boston pharmaceutical company on Thursday, calling it a “first-in-class” treatment that avoids the addictive risks of opioid-based ...

This marks the first approval of a new class of pain relief drugs in more than 20 years, according to a Jan. 30 news release from the agency. Suzetrigine, developed by Vertex Pharmaceuticals, works by ...

An investigation of the epidemiology and clinical characteristics of neuropathic pain in the UK Biobank has led to the discovery of a new pain gene and potential analgesic drug target in the ...